As a result, another patient with advanced pancreatic cancer not reported here was found to have an MLH1 gene mutation on our routine screening for MMR genes and treated with a PD1 inhibitor resulting in a partial response. This evidence concerns the gene MRC1 and familial pancreatic carcinoma.